Baxter International Inc.

NYSE:BAX Rapporto sulle azioni

Cap. di mercato: US$17.0b

Baxter International Gestione

Gestione criteri di controllo 4/4

Baxter International Il CEO è Joe Almeida, nominato in Jan2016, e ha un mandato di 8.83 anni. la retribuzione annua totale è $ 13.79M, composta da 9.4% di stipendio e 90.6% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.11% delle azioni della società, per un valore di $ 18.93M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 2.1 anni e 4.8 anni.

Informazioni chiave

Joe Almeida

Amministratore delegato

US$13.8m

Compenso totale

Percentuale dello stipendio del CEO9.4%
Mandato del CEO8.8yrs
Proprietà del CEO0.1%
Durata media del management2.1yrs
Durata media del Consiglio di amministrazione4.8yrs

Aggiornamenti recenti sulla gestione

Recent updates

Is Baxter International Inc. (NYSE:BAX) Trading At A 49% Discount?

Sep 05
Is Baxter International Inc. (NYSE:BAX) Trading At A 49% Discount?

Baxter- Reiterating Our Buy Rating After A Promising Q2

Aug 07

Baxter International (NYSE:BAX) Will Pay A Dividend Of $0.29

Aug 07
Baxter International (NYSE:BAX) Will Pay A Dividend Of $0.29

Baxter International (NYSE:BAX) Has Affirmed Its Dividend Of $0.29

Jul 23
Baxter International (NYSE:BAX) Has Affirmed Its Dividend Of $0.29

Baxter: Why Investors Should Take Advantage Of The Low Valuation

Jul 16

Little Excitement Around Baxter International Inc.'s (NYSE:BAX) Revenues

Jul 12
Little Excitement Around Baxter International Inc.'s (NYSE:BAX) Revenues

Baxter International (NYSE:BAX) Has Affirmed Its Dividend Of $0.29

May 30
Baxter International (NYSE:BAX) Has Affirmed Its Dividend Of $0.29

Baxter International (NYSE:BAX) Is Due To Pay A Dividend Of $0.29

May 14
Baxter International (NYSE:BAX) Is Due To Pay A Dividend Of $0.29

Baxter International: Shares Too Cheap, EPS Growth Ahead With A Possible Spinoff

May 08

Capital Allocation Trends At Baxter International (NYSE:BAX) Aren't Ideal

Apr 14
Capital Allocation Trends At Baxter International (NYSE:BAX) Aren't Ideal

Broyhill - Baxter International: Renal Care Spin-Off And Recent Revamp Should Provide Catalysts

Feb 23

Baxter International's (NYSE:BAX) Dividend Will Be $0.29

Feb 20
Baxter International's (NYSE:BAX) Dividend Will Be $0.29

Here's Why Baxter International (NYSE:BAX) Has A Meaningful Debt Burden

Jan 28
Here's Why Baxter International (NYSE:BAX) Has A Meaningful Debt Burden

Baxter International (NYSE:BAX) Could Be Struggling To Allocate Capital

Jan 12
Baxter International (NYSE:BAX) Could Be Struggling To Allocate Capital

Baxter International Inc.'s (NYSE:BAX) Prospects Need A Boost To Lift Shares

Dec 28
Baxter International Inc.'s (NYSE:BAX) Prospects Need A Boost To Lift Shares

Baxter International: A Cheap Big Pharma Stock With Improving Earnings And +3% Dividend Yield

Dec 12

Estimating The Fair Value Of Baxter International Inc. (NYSE:BAX)

Nov 27
Estimating The Fair Value Of Baxter International Inc. (NYSE:BAX)

Is Baxter International (NYSE:BAX) A Risky Investment?

Oct 27
Is Baxter International (NYSE:BAX) A Risky Investment?

Should You Buy Baxter Or DaVita After The Fallout From The Ozempic Trial?

Oct 12

There Are Reasons To Feel Uneasy About Baxter International's (NYSE:BAX) Returns On Capital

Sep 21
There Are Reasons To Feel Uneasy About Baxter International's (NYSE:BAX) Returns On Capital

Baxter International (NYSE:BAX) Is Due To Pay A Dividend Of $0.29

Aug 23
Baxter International (NYSE:BAX) Is Due To Pay A Dividend Of $0.29

Dividend Challengers Review: Baxter International

Aug 14

Baxter International (NYSE:BAX) Has Announced A Dividend Of $0.29

Jul 25
Baxter International (NYSE:BAX) Has Announced A Dividend Of $0.29

Baxter International (NYSE:BAX) Has A Somewhat Strained Balance Sheet

Jul 14
Baxter International (NYSE:BAX) Has A Somewhat Strained Balance Sheet

Baxter International: Hillrom Acquisition Could Be A Tailwind For FCF

Jun 12

Returns On Capital At Baxter International (NYSE:BAX) Paint A Concerning Picture

Jun 07
Returns On Capital At Baxter International (NYSE:BAX) Paint A Concerning Picture

Baxter International's (NYSE:BAX) Dividend Will Be $0.29

May 19
Baxter International's (NYSE:BAX) Dividend Will Be $0.29

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Joe Almeida rispetto agli utili di Baxter International?
DataCompenso totaleStipendioGuadagni aziendali
Sep 30 2024n/an/a

US$121m

Jun 30 2024n/an/a

US$98m

Mar 31 2024n/an/a

-US$38m

Dec 31 2023US$14mUS$1m

-US$76m

Sep 30 2023n/an/a

US$96m

Jun 30 2023n/an/a

-US$3b

Mar 31 2023n/an/a

-US$3b

Dec 31 2022US$14mUS$1m

-US$3b

Sep 30 2022n/an/a

-US$3b

Jun 30 2022n/an/a

US$876m

Mar 31 2022n/an/a

US$992m

Dec 31 2021US$16mUS$1m

US$1b

Sep 30 2021n/an/a

US$1b

Jun 30 2021n/an/a

US$1b

Mar 31 2021n/an/a

US$1b

Dec 31 2020US$16mUS$1m

US$1b

Sep 30 2020n/an/a

US$911m

Jun 30 2020n/an/a

US$924m

Mar 31 2020n/an/a

US$991m

Dec 31 2019US$14mUS$1m

US$1b

Sep 30 2019n/an/a

US$1b

Jun 30 2019n/an/a

US$1b

Mar 31 2019n/an/a

US$2b

Dec 31 2018US$16mUS$1m

US$2b

Sep 30 2018n/an/a

US$1b

Jun 30 2018n/an/a

US$795m

Mar 31 2018n/an/a

US$840m

Dec 31 2017US$15mUS$1m

US$609m

Compensazione vs Mercato: La retribuzione totale di Joe ($USD 13.79M ) è circa la media per le aziende di dimensioni simili nel mercato US ($USD 12.66M ).

Compensazione vs guadagni: La retribuzione di Joe è stata coerente con le performance aziendali dell'ultimo anno.


AMMINISTRATORE DELEGATO

Joe Almeida (62 yo)

8.8yrs

Mandato

US$13,786,671

Compensazione

Mr. Jose E. Almeida, also known as Joe, has been the Chairman of the Board and Chief Executive Officer of Baxter International Inc. since January 1, 2016 and serves as its President since January 01, 2016....


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Jose Almeida
Chairman of the Board8.8yrsUS$13.79m0.11%
$ 18.9m
Joel Grade
Executive VP1.1yrsUS$5.37m0%
$ 0
Heather Knight
Executive VP & Group President of Medical Products and Therapies1.7yrsUS$4.86m0.031%
$ 5.3m
Alok Sonig
Executive VP & Group President of Pharmaceuticals2.3yrsUS$3.87m0.0024%
$ 400.2k
Christopher Toth
Executive VP & Group President of Kidney Care1.4yrsUS$9.64m0.0046%
$ 773.2k
Tobi Karchmer
Senior VP and Chief Medical & Scientific Officer1.8yrsNessun datoNessun dato
Charles Patel
Senior VP & Chief Information Officerless than a yearNessun datoNessun dato
Clare Trachtman
Vice President of Investor Relationsno dataNessun datoNessun dato
David Rosenbloom
Executive VP & General Counsel2.6yrsUS$5.66m0.0018%
$ 306.9k
Stacey Eisen
Senior Vice Presidentno dataNessun datoNessun dato
Jeanne Mason
Executive VP & Chief Human Resources Officer7.5yrsUS$4.14m0.037%
$ 6.3m
James Borzi
Executive VP & Chief Supply Chain Officer4.8yrsNessun dato0.0036%
$ 608.7k

2.1yrs

Durata media

54yo

Età media

Gestione esperta: Il team dirigenziale di BAX è considerato esperto (durata media dell'incarico 2.1 anni).


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Jose Almeida
Chairman of the Board8.8yrsUS$13.79m0.11%
$ 18.9m
Stephen Rusckowski
Independent Director1.3yrsUS$197.82k0.0018%
$ 301.8k
Robert Parkinson
Chairman Emeritus8.8yrsUS$17.88mNessun dato
Peter Wilver
Independent Director2.5yrsUS$349.64k0.0026%
$ 440.9k
Stephen Newman Oesterle
Independent Director7.8yrsUS$373.98k0.0055%
$ 925.8k
Patricia Morrison
Independent Director5.8yrsUS$364.98k0.0042%
$ 708.8k
Nancy Schlichting
Independent Director2.9yrsUS$363.00k0.0028%
$ 474.8k
Catherine Smith
Independent Director7.8yrsUS$367.31k0.0044%
$ 749.5k
David Shafer
Lead Independent Director2.5yrsUS$382.31k0.0026%
$ 440.9k
David Wilkes
Independent Director3.8yrsUS$357.00k0.0032%
$ 540.9k
William Ampofo
Independent Director1.4yrsUS$226.35k0.0019%
$ 327.3k
Amy Wendell
Independent Director5.8yrsUS$352.98kNessun dato

4.8yrs

Durata media

66yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di BAX sono considerati esperti (durata media dell'incarico 4.8 anni).